Transcription
Let's talk to Janhavi. Good morning, Janhavi. Tell us the important news and triggers for today. Absolutely, good morning. Today's important, main, and foremost, we will have to keep an eye on the RBI policies. Apart from that, India's GDP figure for Q4 will be seen coming here. If we look at the estimates, it is 7.2%. There is an ex-date for quite a few counters, in which today is the ex-date for Wipro's buyback. The board had announced a buyback of approximately ₹15,000 crore. If we also look at the floor price, it was fixed at ₹250 here. Reliance Industries also has its ex-date today for ₹6. Bank of Maharashtra, JSW Energy, ICICI Prudential, Life Insurance, HDFC AMC, SPL, Bank of Baroda – for all of these, today is the ex-date for interim dividends. So, action will be seen in the prices here. Along with that, the anchor lock-in is going to open for EMI Technology, a company that was recently listed. Its 30-day anchor lock-in will be seen opening today. Also, today I will keep an eye on the fact that the price band for 515 stocks has been seen revised here. For quite a few stocks, if we look at the price band, it has become 20% from 10%, including counters like Ola Electric, IDBI Bank, ITC. And for stocks whose price band has increased from 5% to 10%, companies like LX Industries, Sheetal, Solara, Lotus Developers, AID blenders are included. Also, US jobs data will come today. So, we will have to keep an eye on this as well. CMR Green Technologies' IPO is going to close today. It has received quite good subscription figures so far. If we look at the total, this IPO has been subscribed approximately 9.6 times. Retail subscription has also been seen coming at approximately eight times here. A new IPO will also be seen opening in the market today. Hexagon Nutrition will remain open until June 9th. The price band that has been fixed is ₹42 to ₹45, and if we also look at the total issue size, it is approximately ₹140 crore, in which the entire portion is of OFS. In the news, Aurobindo Pharma will have to be kept an eye on because a big achievement has been seen. Approval has been received from USFDA for Tofacitinib tablets. This medicine is used in the treatment of arthritis. And if we look at its market size in the US, it is a market size of approximately ₹4730 crore. This is a very big market for the company. So, a very big update has been seen. Some QIP issues have also closed, in which, first of all, Ola Electric QIP has received a very good response here. The company has raised ₹780 crore. There are quite a few big funds, including Mirae Asset Funds, GM Financial Funds, Motilal Oswal's funds, which are seen to be included here. A QIP of Solar Industries has also closed. The company has raised ₹2800 crore through QIP. In which big names that have come forward are ICICI Prudential, Nippon Funds, HDFC Funds, SBI Funds, and such big funds are seen to have come forward. Indigo will also have to be focused on, because after the surge in crude oil, the company has cancelled its flights on six international routes here. It has suspended them. They will be seen suspended until September 30th. For cities like Hong Kong, Shanghai, Langkawi, Krabi, if we look, all of these have been suspended. ICICI Bank has received a warning letter from all. It has been seen receiving a warning letter for violation of FEMA rules, and yesterday, there was an analyst meet of theirs, so in the investor presentation, the company has said that they will launch their antibiotic, Zynic, in Europe and emerging markets in 2 years. Also, if we talk about Groww, a big block deal happened yesterday in which Goldman Sachs bought a stake of approximately 18%. But in the name of the seller, Free Fund has been seen selling the stake. Thank you, Janhavi, for all the details.